Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Deciphera Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DCPH
Nasdaq
8731
https://www.deciphera.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Deciphera Pharmaceuticals Inc
Companies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growth
- Mar 24th, 2024 2:19 pm
Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
- Mar 14th, 2024 3:30 pm
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 20.8% Since Last Earnings Report?
- Mar 7th, 2024 4:31 pm
11 Best Small Cap Pharma Stocks to Invest In
- Mar 5th, 2024 1:28 am
Wall Street Analysts Think Deciphera Pharmaceuticals, Inc. (DCPH) Could Surge 48.49%: Read This Before Placing a Bet
- Feb 28th, 2024 2:55 pm
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
- Feb 27th, 2024 12:00 pm
Wall Street Analysts Believe Deciphera Pharmaceuticals, Inc. (DCPH) Could Rally 59.63%: Here's is How to Trade
- Feb 12th, 2024 2:55 pm
Analysts Are Updating Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Estimates After Its Annual Results
- Feb 8th, 2024 10:57 am
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2023 Earnings Call Transcript
- Feb 7th, 2024 2:20 pm
Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat
- Feb 7th, 2024 1:28 pm
Q4 2023 Deciphera Pharmaceuticals Inc Earnings Call
- Feb 7th, 2024 5:33 am
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
- Feb 6th, 2024 12:00 pm
Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
- Feb 1st, 2024 9:50 pm
Nurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
- Feb 1st, 2024 3:01 pm
Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- Feb 1st, 2024 12:00 pm
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Should You Buy?
- Jan 30th, 2024 3:01 pm
Strong week for Deciphera Pharmaceuticals (NASDAQ:DCPH) shareholders doesn't alleviate pain of three-year loss
- Jan 29th, 2024 11:34 am
Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
- Jan 18th, 2024 4:13 pm
Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company
- Jan 8th, 2024 12:00 pm
Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18
- Jan 5th, 2024 12:00 pm
Scroll